In a key development in the high-profile assassination of UnitedHealthcare CEO Brian Thompson, legal representatives for accused shooter Luigi Mangione are set to hold a closed-door meeting with federal prosecutors this Friday, according to multiple U.S. media reports citing speculation over a potential plea agreement.
Mangione is currently facing two federal charges of stalking tied to the 2024 killing in New York City. Conviction on both counts could result in a maximum sentence of life imprisonment without the possibility of parole, though officials have not yet confirmed which specific charges are on the negotiating table. This week, Jamie McDonald, U.S. Attorney for the Southern District of New York (SDNY), confirmed the scheduling of the meeting, telling reporters only that “There’s a conference scheduled for 11 am on Friday, and that’s all we can say at this time.”
Beyond the federal prosecution, Mangione also faces identical murder-related charges in a separate New York state court proceeding. To date, the accused has entered not guilty pleas to every charge brought in both cases. Legal experts emphasize that ongoing discussions about a plea deal do not guarantee a final agreement will be reached: such negotiations can collapse at any stage, and any finalized deal requires formal approval from a sitting judge before it can take effect.
Federal prosecutors brought the stalking charges after alleging Mangione traveled across the country and conducted pre-attack surveillance of Thompson before carrying out the killing. In a key ruling earlier this year, a federal judge dismissed two additional charges against Mangione in January, one of which would have allowed prosecutors to pursue the death penalty if the accused was convicted.
All three relevant legal bodies – Mangione’s defense team, the SDNY, and the Manhattan District Attorney’s office – declined to respond to multiple requests for comment from the BBC when reached earlier this week. Mangione’s legal team has long challenged the dual prosecutions, arguing that trying their client in both state and federal court for the same killing violates fundamental legal principles. Presiding judges for both cases have so far rejected that challenge and allowed both proceedings to move forward.
However, a guilty plea in the federal case could upend the scheduled state trial. If a plea deal is finalized, defense attorneys will likely argue that the state prosecution violates the Fifth Amendment’s double jeopardy clause, a core constitutional protection that bars individuals from being prosecuted twice for the same offense. New York’s state constitution also includes its own explicit ban on double jeopardy, which would add further weight to this legal argument if it is raised, potentially derailing the state case entirely.
Mitchell Epner, a former federal prosecutor and currently a white-collar defense attorney not affiliated with the case, explained the broader legal context: “If a federal prosecution has been completed on a matter, the state cannot prosecute the matter on those same facts.”
Currently, Mangione’s state trial is scheduled to open on September 8, while the federal trial is currently slated to begin in January 2027. If a plea deal is reached in the federal case, the timeline and future of the state trial will be thrown into uncertainty, reshaping the trajectory of one of the most high-profile criminal cases in the United States this year.